首页> 美国卫生研究院文献>Cell Death Disease >The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity based on the bis(arylidene)cyclohexanone scaffold
【2h】

The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity based on the bis(arylidene)cyclohexanone scaffold

机译:基于双(亚芳基)环己酮骨架的具有选择性促死亡活性的部分选择性异肽酶抑制剂的结合态势

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diaryldienone derivatives with accessible β-carbons show strong anti-neoplastic properties, related to their ability to make covalent adducts with free thiols by Michael addition, and low toxicity in vivo. Accumulation of poly-ubiquitylated proteins, activation of the unfolded protein response (UPR) and induction of cell death are universal hallmarks of their activities. These compounds have been characterized as inhibitors of isopeptidases, a family of cysteine-proteases, which de-conjugate ubiquitin and ubiquitin-like proteins from their targets. However, it is unclear whether they can also react with additional proteins. In this work, we utilized the biotin-conjugated diaryldienone-derivative named 2c, as a bait to purify novel cellular targets of these small molecules. Proteomic analyses have unveiled that, in addition to isopeptidases, these inhibitors can form stable covalent adducts with different intracellular proteins, thus potentially impacting on multiple functions of the cells, from cytoskeletal organization to metabolism. These widespread activities can explain the ability of diaryldienone derivatives to efficiently trigger different cell death pathways.
机译:具有可及的β-碳原子的二芳基二烯酮衍生物具有很强的抗肿瘤特性,这与它们通过迈克尔加成反应与游离硫醇形成共价加合物的能力有关,并且体内毒性低。多泛素化蛋白的积累,未折叠蛋白应答(UPR)的激活和细胞死亡的诱导是其活性的普遍特征。这些化合物已被表征为异肽酶的抑制剂,这是一个半胱氨酸蛋白酶家族,可将泛素和类泛素蛋白从其靶标上解偶联。但是,尚不清楚它们是否也可以与其他蛋白质反应。在这项工作中,我们利用生物素共轭的二芳基二烯酮衍生物2c作为诱饵来纯化这些小分子的新型细胞靶标。蛋白质组学分析表明,除异肽酶外,这些抑制剂还可以与不同的细胞内蛋白形成稳定的共价加合物,从而潜在地影响从细胞骨架组织到新陈代谢的细胞多种功能。这些广泛的活动可以解释二芳基二烯酮衍生物有效触发不同细胞死亡途径的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号